da Rocha, Jorge E. B. http://orcid.org/0000-0002-1386-5367
Othman, Houcemeddine
Tiemessen, Caroline T.
Botha, Gerrit http://orcid.org/0000-0001-7499-3760
Ramsay, Michèle http://orcid.org/0000-0002-4156-4801
Masimirembwa, Collen
Adebamowo, Clement
Choudhury, Ananyo
Brandenburg, Jean-Tristan
Matshaba, Mogomotsi
Simo, Gustave
Gamo, Francisco-Javier
Hazelhurst, Scott http://orcid.org/0000-0002-0581-149X
da Rocha, Jorge E. B.
,
Article History
Received: 8 June 2020
Accepted: 12 May 2021
First Online: 23 July 2021
Compliance with ethical standards
:
: GlaxoSmithKline (GSK) had no part in the design of this study or analysis presented here and the views and opinions expressed are not necessarily those of GSK. The authors acknowledge the financial support of GSK. FJG is an employee of GlaxoSmithKline.
: The HAAD and AWI-Gen datasets used in this work were previously generated. Ethics approval and informed consent was obtained at each collaborative centre. The reference numbers for each correspond as follows (Study; Review Board; Protocol Number): H3A AWI-Gen Study; Human Research Ethics Committee (Medical) of the University of the Witwatersrand (Wits); M121029 and M170880. H3A Benin Study; Comité d’éthique de la recherche, Université de Montréal; N/A. H3A CAfGEN Study; IRB of the Ministry of Health of the Republic of Botswana; PPPME-13/18/1. H3A TrypanoGEN Study; Comité National D’Ethique de la Recherche pour la Santé Humaine of the Republic of Cameroon; No 2013/11/364/L/CNERSH/SP. H3A ACCME Study; The National Health Research Ethics Committee of Nigeria; NHREC/01/01/2007- 29/11/2016. H3A TrypanoGEN Study; Biomedical Research Ethics Committee of the University of Zambia; FWA00000338. Cell Biology Research Lab—NICD/Wits; Human Research Ethics Committee (Medical) of the University of the Witwatersrand (Wits); M140926.